Understand the source comparison
Comparisons: NAD+ Itself Versus Its Precursors
“NAD+” in the supplement and research-chemical world is usually shorthand for a family of related molecules, and they are not interchangeable. Understanding the differences clarifies why the literature can seem contradictory. NAD+ itself is a large, charged mo
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- “NAD+” in the supplement and research-chemical world is usually shorthand for a family of related molecules, and they are not interchangeable. Understanding the differences clarifies why the literature can seem contradictory.
- NAD+ itself is a large, charged molecule that is not efficiently absorbed intact when taken by mouth, and it is thought to be largely broken down into precursors in the gut before entering cells. This is why most oral products are precursors rather than NAD+ itself, and why some settings use intravenous NAD+ or, in research contexts, injectable formulations. The precursors each enter NAD+ synthesis at a different point.
- Nicotinic acid (niacin)
- Vitamin B3 form
- Preiss-Handler pathway
- Long history; causes flushing at higher doses; used for lipids
- Nicotinamide (niacinamide)
- Salvage pathway
- No flushing; feedback-inhibits sirtuins at high levels
- Nicotinamide riboside (NR)
- Riboside precursor
- Salvage pathway (via NRK enzymes)
- Most human RCT data; raises blood NAD+ dose-dependently7
- Nicotinamide mononucleotide (NMN)
- Nucleotide precursor
- One step from NAD+
- Widely studied; contested regulatory status9,13
- NAD+ (intact)
- Coenzyme itself
- N/A (poor oral uptake)
- Used IV or injectable in some research settings
- The two most-discussed research precursors are NR and NMN. NR enters the salvage pathway and is converted first to NMN and then to NAD+; NMN sits one enzymatic step from NAD+. Debate persists over whether NMN must be dephosphorylated to NR to cross cell membranes or whether a dedicated NMN transporter exists, and this transport question is one reason the two compounds are studied side by side. In practice, both reliably raise blood NAD+ in human trials.7,9 Nicotinamide and nicotinic acid, the classic vitamin B3 forms, also raise NAD+ but carry their own quirks: high-dose nicotinamide can inhibit sirtuins through feedback, and nicotinic acid causes the well-known niacin flush.
- It is also worth situating NAD+ against adjacent compounds that researchers pair with it or study in the same longevity-metabolism space. Some agents aim to spare NAD+ rather than supply it, such as inhibitors of the enzyme NNMT, which are theorized to preserve nicotinamide for NAD+ synthesis. Readers exploring these categories can compare, for example, the research profiles of 5-Amino-1MQ and its higher-strength vial format, along with mitochondrial-targeted peptides such as SS-31 and longevity-oriented peptides such as Epithalon. None of these comparisons implies that any of them prevents disease; they simply map the neighborhood of compounds that intersect with NAD+ biology in the research literature. A broader index of these compounds and their study-based reconstitution details is maintained on the peptide dosages catalog.